A 32-Year-Old Man C-ANCA Vasculitis Having Sudden Onset Blindness Due To Non-Proliferative Retinopathy and Exudative Maculopathy Treated Successfully with Intravitreal Injection of Bevacizumab: A Rare Case Report

Article Sidebar

PDF
Published: Nov 25, 2024
DOI: https://doi.org/10.47191/ijmscrs/v4-i11-32
Keywords:
c-ANCA vasculitis, blindness, exudative maculopathy, non-proliferative retinopathy, bevacizumab

Main Article Content

Khin Phyu Pyar
Professor and Head/ Senior Consultant Physician and Nephrologist, Department of Medicine/Nephrology, Defence Services Medical Academy/ No. (1) Defence Services General Hospital (1000-Bedded), Yangon, Myanmar.
Zayar Tun
Lecturer, Department of Ophthalmology, Defence Services Medical Academy, Myanmar.
Tun Min Aung
Associate Professor and Head of Department, Department of ophthalmology, Defence Services Medical Academy, Myanmar.
Aung Nyan Lynn
Consultant Physician, No. (1) Defence Services General Hospital (1000-Bedded), Yangon, Myanmar.
Soe Win Hlaing
Senior Consultant Physician, No. (1) Defence Services General Hospital (1000-Bedded), Yangon, Myanmar.
Aung Phyoe Kyaw
Consultant Physician, No. (1) Defence Services General Hospital (1000-Bedded), Yangon, Myanmar.
Zar Ni Htet Aung
Consultant Physician, No. (1) Defence Services General Hospital (1000-Bedded), Yangon, Myanmar.
Thurein Win
Consultant Physician, No. (1) Defence Services General Hospital (1000-Bedded), Yangon, Myanmar.

Abstract

The patient was a 32-year-old doctor known case of c-ANCA positive vasculitis developed sudden onset blurring vision on his left eye. Visual acuity was 6/12 right eye and 6/18 on left eye. Ophthalmic examination revealed exudative maculopathy with non-proliferative retinopathy on both eye; severe on left side. He was treated successfully with three dose of monthly intravitreal bevacizumab injections. He was on corticosteroids for pauci-immune glomerulonephritis and maintenance hemodialysis as a renal replacement therapy.

Article Details

How to Cite
Khin Phyu Pyar, Zayar Tun, Tun Min Aung, Aung Nyan Lynn, Soe Win Hlaing, Aung Phyoe Kyaw, Zar Ni Htet Aung, & Thurein Win. (2024). A 32-Year-Old Man C-ANCA Vasculitis Having Sudden Onset Blindness Due To Non-Proliferative Retinopathy and Exudative Maculopathy Treated Successfully with Intravitreal Injection of Bevacizumab: A Rare Case Report. International Journal of Medical Science and Clinical Research Studies, 4(11), 2063–2072. https://doi.org/10.47191/ijmscrs/v4-i11-32
Issue
Vol. 4 No. 11 (2024): Volume 04 Issue 11 November 2024
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Abu El-Asrar, A. M., Herbort, C. P., & Tabbara, K. F. (2009). Differential diagnosis of retinal vasculitis. Middle East African Journal of Ophthalmology, 16(4), 202–218. https://doi.org/10.4103/0974-9233.58423

II. Agarwal, A., Rübsam, A., Zur Bonsen, L., Pichi, F., Neri, P., & Pleyer, U. (2022). A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments. Journal of Clinical Medicine, 11(9). https://doi.org/10.3390/jcm11092525

III. Aliya, S., & T, S. (2021). Retinal vasculitis – Clinical manifestations and outcome at tertiary eye care centre in south India. Indian Journal of Clinical and Experimental Ophthalmology, 2021, 14883. https://doi.org/10.18231/j.ijceo.2021.111

IV. Alrashidi, S., Yousef, Y., & Krema, H. (2013). Visual loss from scleritis in C-ANCA-positive microscopic polyangiitis. BMJ Case Reports, 2013. https://doi.org/10.1136/bcr-2013-009583

V. Cackett, P., & Singh, J. (2006). Churg–Strauss syndrome in association with proliferative retinopathy. Eye, 20(3), 394–396.

https://doi.org/10.1038/sj.eye.6701871

VI. Carreño, E., & Olivas-Vergara, O. M. (2023). Systemic Vasculitis and Its Association with the Eye. Ophthalmologica, 246(3–4), 174–180. https://doi.org/10.1159/000531395

VII. D’Aquila, M. L., & John, V. J. (2022). Granulomatosis With Polyangiitis Presenting as Occlusive Retinal Vasculitis. Journal of VitreoRetinal Diseases, 6(6), 467–469.

https://doi.org/10.1177/24741264221076358

VIII. Das, T., Pathengay, A., Hussain, N., & Biswas, J. (2010). Eales’ disease: Diagnosis and management. Eye, 24(3), 472–482.

https://doi.org/10.1038/eye.2009.315

IX. Farrah, T. E., Basu, N., Dweck, M., Calcagno, C., Fayad, Z. A., & Dhaun, N. (2019). Advances in Therapies and Imaging for Systemic Vasculitis. Arteriosclerosis, Thrombosis, and Vascular Biology, 39(8), 1520–1541.

https://doi.org/10.1161/ATVBAHA.118.310957

X. Hoang, L. T., Lim, L. L., Vaillant, B., Choi, D., & Rosenbaum, J. T. (2008). Antineutrophil Cytoplasmic Antibody–Associated Active Scleritis. Archives of Ophthalmology, 126(5), 651–655. https://doi.org/10.1001/archopht.126.5.651

XI. Junek, M. L., Zhao, L., Garner, S., Cuthbertson, D., Pagnoux, C., Koening, C. L., Langford, C. A., McAlear, C. A., Monach, P. A., Moreland, L. W., Rhee, R. L., Seo, P., Specks, U., Sreih, A. G., Warrington, K., Wechsler, M. E., Merkel, P. A., & Khalidi, N. A. (2023). Ocular manifestations of ANCA-associated vasculitis. Rheumatology (Oxford, England), 62(7), 2517–2524. https://doi.org/10.1093/rheumatology/keac663

XII. Junek, M., Zhao, L., Garner, S., Cuthbertson, D., Pagnoux, C., Koening, C., Langford, C., McAlear, C., Monach, P., Moreland, L., Rhee, R., Seo, P., Specks, U., Sreih, A., Warrington, K., Wechsler, M., Merkel, P., & Khalidi, N. (2022). Ocular manifestations of ANCA-associated vasculitis. Rheumatology, 62. https://doi.org/10.1093/rheumatology/keac663

XIII. Ku, J. H., Ali, A., Suhler, E. B., Choi, D., & Rosenbaum, J. T. (2012). Characteristics and Visual Outcome of Patients With Retinal Vasculitis. Archives of Ophthalmology, 130(10), 1261–1266. https://doi.org/10.1001/archophthalmol.2012.1596

XIV. Li, Z.-Y., Kang, M., Qian, X.-Z., Peng, R., Hong, Q., Ying, P., Huang, H., Wang, X.-Y., Zeng, Y.-M., Hu, J.-Y., Chen, X., Wu, R., Shao, Y., & Yu, S.-J. (2024). Retinal thickness and microvascular alterations observed by optical coherence tomography in antineutrophil cytoplasmic antibody-associated vasculitis: A cross-sectional study. 2024, 14(7), 4998–5011.

XV. Marcus, D. M., Frederick, A. R., Raizman, M. B., & Shore, J. W. (1995). Choroidal and Retinal Detachment in Antineutrophil Cytoplasmic Antibody-Positive Scleritis. American Journal of Ophthalmology, 119(4), 517–519.

https://doi.org/10.1016/S0002-9394(14)71243-7

XVI. Menia, N. K., Alcibahy, Y., Pichi, F., Neri, P., & Agarwal, A. (2024). An Update on Noninfectious Retinal Vasculitis. Ophthalmologica, 247(3), 133–146. https://doi.org/10.1159/000539608

XVII. Özdal, P. Ç., & Tugal-Tutkun, I. (2022). Choroidal involvement in systemic vasculitis: A systematic review. Journal of Ophthalmic Inflammation and Infection, 12(1), 14. https://doi.org/10.1186/s12348-022-00292-4

XVIII. Pakrou, N., Selva, D., & Leibovitch, I. (2006). Wegener’s granulomatosis: Ophthalmic manifestations and management. Seminars in Arthritis and Rheumatism, 35(5), 284–292. https://doi.org/10.1016/j.semarthrit.2005.12.003

XIX. Talat, L., Lightman, S., & Tomkins-Netzer, O. (2014). Ischemic Retinal Vasculitis and Its Management. Journal of Ophthalmology, 2014(1), 197675. https://doi.org/10.1155/2014/197675

XX. Triggianese, P., D’Antonio, A., Nesi, C., Kroegler, B., Di Marino, M., Conigliaro, P., Modica, S., Greco, E., Nucci, C., Bergamini, A., Chimenti, M., & Cesareo, M. (2023). Subclinical microvascular changes in ANCA-vasculitides: The role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage. Orphanet Journal of Rare Diseases, 18(1), 184. https://doi.org/10.1186/s13023-023-02782-7

XXI. Zhioua Braham, I., Boukari, M., Mokrani, M., Errais, K., Mili, I., & Zhioua, R. (2024). Multimodal imaging of bilateral occlusive retinal vasculitis and proliferative retinopathy in systemic sclerosis. Journal Français d’Ophtalmologie, 47(1), 103932. https://doi.org/10.1016/j.jfo.2023.08.003

Most read articles by the same author(s)